Benjamin Wolin Insider Profile
4 Followers
Benjamin Wolin, Director at Rockwell Med, holds 0.00 shares in Covetrus (Ticker: CVET), holds 0.00 shares in Diplomat Pharmacy (Ticker: DPLO), holds 27.71K shares in Rockwell Med (Ticker: RMTI).
Benjamin Wolin's Trading History
| CVETCovetrus | Oct 13, 2022 | ― | Uninformative Sell | ― | $0.00 | |
| DPLODiplomat Pharmacy | Feb 10, 2020 | ― | Uninformative Sell | 133.04K | $0.00 | |
| RMTIRockwell Med | Jun 10, 2019 | Director | Uninformative Buy | ― | $194.80K | |
| EVDYEveryday Health | Nov 17, 2016 | ― | Uninformative Buy | 2.00K | $5.39M |
You May Also Like
Benjamin Wolin insider profile FAQ
What is the percentage of profitable transactions made by Benjamin Wolin?
The percentage of profitable transactions made by Benjamin Wolin is 100%.
What is the average return per transaction made by Benjamin Wolin?
The average return per transaction made by Benjamin Wolin is 44.60%.
What stocks does Benjamin Wolin hold?
Benjamin Wolin holds: RMTI, EVDY, CVET, DPLO stocks.
What was Benjamin Wolin's most profitable transaction?
Benjamin Wolin’s most profitable transaction was an Informative Sell of DPLO stock on June 5, 2018. The return on the trade was 81.10%.
What is Benjamin Wolin's role in Rockwell Med?
Benjamin Wolin's role in Rockwell Med is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
